跳至主要内容
临床试验/EUCTR2016-001940-20-GB
EUCTR2016-001940-20-GB进行中(未招募)1 期

A Pilot, Randomised, Unblinded, Feasibility, Safety, Biochemical and Physiological Efficacy Study of 20% vs 5% Human Albumin Solution for Fluid Bolus Therapy in Critically Ill Adults - Small volume resuscitation with albumin in intensive care (SWIPE)

Central Manchester University Hospitals NHS Foundation Trust0 个研究点目标入组 400 人开始时间: 2016年10月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Admitted to the intensive care unit for less than 24 hours.
  • Age 18 years or greater
  • Need for fluid bolus as determined by the treating clinician
  • Presence of one or more of the following physiological states: systolic BP <90 mmHg, or MAP <65 mmHg, or increasing need for vasopressor drug infusion or pulse pressure variation >12 % or stroke volume variation >12%, or Cardiac index <2.2 L/min/m2 or heart rate >100 or urinary output <20 ml/hr or either rising lactate levels or lactate levels >2 mmol/L or capillary refill time >3 seconds or central venous pressure <8 mmHg.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • Confirmed or suspected pregnancy
  • Patients with traumatic brain injury
  • Active bleeding
  • Haemoglobin level <70 g/L
  • People who refuse blood products
  • Patients in whom death is considered imminent (within 24 hours)

研究者

相似试验